Minerva Neurosciences, Inc. - Common Stock, par value $0.0001 per share (NERV)

CUSIP: 603380205

Q3 2025 13F Holders as of 30 Sep 2025

Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
45,675,986
Total 13F shares
1,979,675
Share change
+35,209
Total reported value
$4,208,645
Price per share
$2.10
Number of holders
22
Value change
+$81,860
Number of buys
8
Number of sells
6

Quarterly Holders Quick Answers

What is CUSIP 603380205?
CUSIP 603380205 identifies NERV - Minerva Neurosciences, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of NERV - Minerva Neurosciences, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
BOEHRINGER INGELHEIM INTERNATIONAL GMBH
3/4/5
10%+ Owner
class O/S missing
1,275,000
$4,794,000 27 Jun 2023
FEDERATED HERMES, INC.
13F
Company
3%
1,351,275
$2,324,193 30 Jun 2025
13F
VANGUARD GROUP INC
13F
Company
0.55%
252,060
$433,544 30 Jun 2025
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.24%
111,000
$190,920 30 Jun 2025
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.17%
75,625
$130,099 30 Jun 2025
13F
BlackRock, Inc.
13F
Company
0.16%
72,669
$124,991 30 Jun 2025
13F
Apella Capital, LLC
13F
Company
0.05%
20,939
$34,340 30 Jun 2025
13F
ACADIAN ASSET MANAGEMENT LLC
13F
Company
0.04%
17,416
$29,000 30 Jun 2025
13F
STATE STREET CORP
13F
Company
0.04%
16,519
$28,413 30 Jun 2025
13F
ADAR1 Capital Management, LLC
13F
Company
0.03%
12,406
$21,338 30 Jun 2025
13F
MORGAN STANLEY
13F
Company
0.02%
11,008
$18,933 30 Jun 2025
13F
Tower Research Capital LLC (TRC)
13F
Company
0%
2,215
$3,810 30 Jun 2025
13F
UBS Group AG
13F
Company
0%
875
$1,505 30 Jun 2025
13F
SBI Securities Co., Ltd.
13F
Company
0%
162
$279 30 Jun 2025
13F
Farther Finance Advisors, LLC
13F
Company
0%
100
$172 30 Jun 2025
13F
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO
13F
Company
0%
100
$172 30 Jun 2025
13F
BNP PARIBAS FINANCIAL MARKETS
13F
Company
0%
62
$107 30 Jun 2025
13F
JONES FINANCIAL COMPANIES LLLP
13F
Company
0%
57
$101 30 Jun 2025
13F
BANK OF AMERICA CORP /DE/
13F
Company
0%
53
$91 30 Jun 2025
13F
RAYMOND JAMES FINANCIAL INC
13F
Company
0%
25
$43 30 Jun 2025
13F
Anchor Investment Management, LLC
13F
Company
0%
12
$21 30 Jun 2025
13F
BARCLAYS PLC
3/4/5
10%+ Owner
class O/S missing
605,230
11 Aug 2022
Jeryl L. Hilleman
3/4/5
Director
class O/S missing
12,500
27 Sep 2023
William F. Doyle
3/4/5
Director
class O/S missing
2,500
10 Jun 2022

Institutional Holders of Minerva Neurosciences, Inc. - Common Stock, par value $0.0001 per share (NERV) as of Q3 2025

As of 30 Sep 2025, Minerva Neurosciences, Inc. - Common Stock, par value $0.0001 per share (NERV) was held by 22 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,979,675 shares. The largest 10 holders included FEDERATED HERMES, INC., VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock, Inc., Apella Capital, LLC, ACADIAN ASSET MANAGEMENT LLC, STATE STREET CORP, ADAR1 Capital Management, LLC, and MORGAN STANLEY. This page lists 22 institutional shareholders reporting positions in this security for the Q3 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2025 vs Q2 2025 Across Filers

Q2 2025 holders
18
Q3 2025 holders
22
Holder diff
4
Investor Q2 2025 Shares Q3 2025 Shares Share Diff Share Chg % Q2 2025 Value $ Q3 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .